Literature DB >> 24638884

Adaptive multimodal treatment for children with attention-deficit-/hyperactivity disorder: an 18 month follow-up.

Manfred Döpfner1, Elena Ise, Tanja Wolff Metternich-Kaizman, Stephanie Schürmann, Christiane Rademacher, Dieter Breuer.   

Abstract

The Cologne Adaptive Multimodal Treatment (CAMT) study demonstrated that adaptive and individually tailored multimodal treatment for attention-deficit/hyperactivity disorder (ADHD) [consisting of behavior therapy (BT) and/or stimulant medication] is highly effective. This study reports findings of the 18 month follow-up assessment. Parents and teachers completed broad range behavior scales (Child Behavior Checklist/Teacher Report Form) and standardized ADHD and oppositional defiant disorder/conduct disorder symptom rating scales. Children that used medication to treat ADHD at follow-up (N = 32) and those that did not (N = 34) were analyzed separately. Parents did not report significant changes in child behavior from posttest to follow-up. Teacher ratings revealed some aggravation of ADHD symptoms in children that received medication, but this was not significant after Bonferroni correction. The initial advantage of combined treatment over BT was no longer evident. It can be concluded that treatment for ADHD that is tailored to the assessed needs of children results in large treatment effects that are maintained for at least 18 months.

Entities:  

Mesh：

Substances：

Year:  2015        PMID： 24638884     DOI： 10.1007/s10578-014-0452-8

Source DB:  PubMed          Journal:  Child Psychiatry Hum Dev        ISSN： 0009-398X


  47 in total

1.  Annotation: randomised trials.

Authors:  Richard C Harrington; Sam Cartwright-Hatton; Alan Stein
Journal:  J Child Psychol Psychiatry       Date:  2002-09       Impact factor: 8.982

2.  ADHD: clinical practice guideline for the diagnosis, evaluation, and treatment of attention-deficit/hyperactivity disorder in children and adolescents.

Authors:  Mark Wolraich; Lawrence Brown; Ronald T Brown; George DuPaul; Marian Earls; Heidi M Feldman; Theodore G Ganiats; Beth Kaplanek; Bruce Meyer; James Perrin; Karen Pierce; Michael Reiff; Martin T Stein; Susanna Visser
Journal:  Pediatrics       Date:  2011-10-16       Impact factor: 7.124

3.  Functional impairment and occupational outcome in adults with ADHD.

Authors:  Bjørn Gjervan; Terje Torgersen; Hans M Nordahl; Kirsten Rasmussen
Journal:  J Atten Disord       Date:  2011-07-01       Impact factor: 3.256

4.  Comparison of the efficacy of two different modified release methylphenidate preparations for children and adolescents with attention-deficit/hyperactivity disorder in a natural setting: comparison of the efficacy of Medikinet(®) retard and Concerta(®)--a randomized, controlled, double-blind multicenter clinical crossover trial.

Authors:  Manfred Döpfner; Claudia Ose; Roland Fischer; Richard Ammer; André Scherag
Journal:  J Child Adolesc Psychopharmacol       Date:  2011-07-26       Impact factor: 2.576

5.  Clinical relevance of the primary findings of the MTA: success rates based on severity of ADHD and ODD symptoms at the end of treatment.

Authors:  J M Swanson; H C Kraemer; S P Hinshaw; L E Arnold; C K Conners; H B Abikoff; W Clevenger; M Davies; G R Elliott; L L Greenhill; L Hechtman; B Hoza; P S Jensen; J S March; J H Newcorn; E B Owens; W E Pelham; E Schiller; J B Severe; S Simpson; B Vitiello; K Wells; T Wigal; M Wu
Journal:  J Am Acad Child Adolesc Psychiatry       Date:  2001-02       Impact factor: 8.829

6.  The adolescent outcome of children with attention deficit hyperactivity disorder treated with methylphenidate or methylphenidate combined with multimodal behaviour therapy: results of a naturalistic follow-up study.

Authors:  S van der Oord; P J M Prins; J Oosterlaan; P M G Emmelkamp
Journal:  Clin Psychol Psychother       Date:  2011-03-14

7.  A meta-analysis of behavioral treatments for attention-deficit/hyperactivity disorder.

Authors:  Gregory A Fabiano; William E Pelham; Erika K Coles; Elizabeth M Gnagy; Andrea Chronis-Tuscano; Briannon C O'Connor
Journal:  Clin Psychol Rev       Date:  2008-11-11

8.  Secondary evaluations of MTA 36-month outcomes: propensity score and growth mixture model analyses.

Authors:  James M Swanson; Stephen P Hinshaw; L Eugene Arnold; Robert D Gibbons; Sue Marcus; Kwan Hur; Peter S Jensen; Benedetto Vitiello; Howard B Abikoff; Laurence L Greenhill; Lily Hechtman; William E Pelham; Karen C Wells; C Keith Conners; John S March; Glen R Elliott; Jeffery N Epstein; Kimberly Hoagwood; Betsy Hoza; Brooke S G Molina; Jeffrey H Newcorn; Joanne B Severe; Timothy Wigal
Journal:  J Am Acad Child Adolesc Psychiatry       Date:  2007-08       Impact factor: 8.829

9.  National Institute of Mental Health Multimodal Treatment Study of ADHD follow-up: changes in effectiveness and growth after the end of treatment.

Authors: 
Journal:  Pediatrics       Date:  2004-04       Impact factor: 7.124

10.  Comparative efficacy and acceptability of methylphenidate and atomoxetine in treatment of attention deficit hyperactivity disorder in children and adolescents: a meta-analysis.

Authors:  Raveen Hanwella; Madhri Senanayake; Varuni de Silva
Journal:  BMC Psychiatry       Date:  2011-11-10       Impact factor: 3.630
View more
  7 in total

1.  Transcranial direct current stimulation improves clinical symptoms in adolescents with attention deficit hyperactivity disorder.

Authors:  Cornelia Soff; Anna Sotnikova; Hanna Christiansen; Katja Becker; Michael Siniatchkin
Journal:  J Neural Transm (Vienna)       Date:  2016-11-16       Impact factor: 3.575

2.  ESCAschool study: trial protocol of an adaptive treatment approach for school-age children with ADHD including two randomised trials.

Authors:  Manfred Döpfner; Christopher Hautmann; Christina Dose; Tobias Banaschewski; Katja Becker; Daniel Brandeis; Martin Holtmann; Thomas Jans; Carolin Jenkner; Sabina Millenet; Tobias Renner; Marcel Romanos; Elena von Wirth
Journal:  BMC Psychiatry       Date:  2017-07-24       Impact factor: 3.630

3.  Sequential treatment of ADHD in mother and child (AIMAC study): importance of the treatment phases for intervention success in a randomized trial.

Authors:  Christopher Hautmann; Manfred Döpfner; Josepha Katzmann; Stephanie Schürmann; Tanja Wolff Metternich-Kaizman; Charlotte Jaite; Viola Kappel; Julia Geissler; Andreas Warnke; Christian Jacob; Klaus Hennighausen; Barbara Haack-Dees; Katja Schneider-Momm; Alexandra Philipsen; Swantje Matthies; Michael Rösler; Wolfgang Retz; Alexander von Gontard; Esther Sobanski; Barbara Alm; Sarah Hohmann; Alexander Häge; Luise Poustka; Michael Colla; Laura Gentschow; Christine M Freitag; Katja Becker; Thomas Jans
Journal:  BMC Psychiatry       Date:  2018-12-13       Impact factor: 3.630

4.  How are behavioural interventions delivered to children (5-11 years old): a systematic mapping review.

Authors:  Amberly Brigden; Roxanne Morin Parslow; Catherine Linney; Nina Higson-Sweeney; Rebecca Read; Maria Loades; Anna Davies; Sarah Stoll; Lucy Beasant; Richard Morris; Siyan Ye; Esther Crawley
Journal:  BMJ Paediatr Open       Date:  2019-12-10

5.  Assessment of the lamina cribrosa in attention-deficit hyperactivity disorder.

Authors:  Serkan Akkaya; Döndü M Ulusoy; Hatice Doğan; Mahmut E Arslan
Journal:  Indian J Ophthalmol       Date:  2021-12       Impact factor: 1.848

6.  Predicting delinquent behavior in young adults with a childhood diagnosis of ADHD: results from the Cologne Adaptive Multimodal Treatment (CAMT) Study.

Authors:  Dieter Breuer; Elena von Wirth; Janet Mandler; Stephanie Schürmann; Manfred Döpfner
Journal:  Eur Child Adolesc Psychiatry       Date:  2020-12-04       Impact factor: 5.349

7.  Parent-child inpatient treatment for children with behavioural and emotional disorders: a multilevel analysis of within-subjects effects.

Authors:  Elena Ise; Sabine Schröder; Dieter Breuer; Manfred Döpfner
Journal:  BMC Psychiatry       Date:  2015-11-16       Impact factor: 3.630
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.